Medirom Healthcare Reports July 2025 KPIs
Ticker: MRM · Form: 6-K · Filed: Aug 20, 2025 · CIK: 1819704
Sentiment: neutral
Topics: kpi, press-release, foreign-private-issuer
TL;DR
Medirom Healthcare dropped its July 2025 KPIs today, check the 6-K for the latest numbers.
AI Summary
Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for July 2025 via a press release on August 20, 2025. The company, based in Tokyo, Japan, is a foreign private issuer filing a Form 6-K report.
Why It Matters
This filing provides investors with updated operational metrics for Medirom Healthcare Technologies Inc., allowing for a timely assessment of the company's performance.
Risk Assessment
Risk Level: low — This is a routine filing of operational data and does not appear to contain significant new financial risks.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Registrant
- August 20, 2025 (date) — Press Release Date
- July 2025 (date) — Reporting Period for KPIs
- Tokyo, Japan (location) — Company Headquarters
FAQ
What specific Key Performance Indicators (KPIs) were announced for July 2025?
The filing states that Medirom Healthcare Technologies Inc. is issuing a press release announcing its major Key Performance Indicators (KPIs) for the month of July 2025, but the specific KPIs are not detailed within this excerpt.
When was the press release announcing the July 2025 KPIs issued?
The press release announcing the July 2025 KPIs was issued on August 20, 2025.
What is the purpose of this Form 6-K filing?
This Form 6-K report is being filed to announce the issuance of a press release by Medirom Healthcare Technologies Inc. regarding its Key Performance Indicators for July 2025.
Where is Medirom Healthcare Technologies Inc. headquartered?
Medirom Healthcare Technologies Inc. is headquartered at 2-3-1 Daiba, Minato-ku, Tokyo, Japan.
Does Medirom Healthcare Technologies Inc. file annual reports under Form 20-F or 40-F?
Medirom Healthcare Technologies Inc. files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Filing Stats: 288 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2025-08-20 06:10:08
Filing Documents
- mrm-20250820x6k.htm (6-K) — 16KB
- mrm-20250820xex99d1.htm (EX-99.1) — 90KB
- mrm-20250820xex99d1001.jpg (GRAPHIC) — 4KB
- mrm-20250820xex99d1003.jpg (GRAPHIC) — 27KB
- mrm-20250820xex99d1004.jpg (GRAPHIC) — 29KB
- mrm-20250820xex99d1005.jpg (GRAPHIC) — 29KB
- mrm-20250820xex99d1006.jpg (GRAPHIC) — 26KB
- mrm-20250820xex99d1007.jpg (GRAPHIC) — 27KB
- mrm-20250820xex99d1008.jpg (GRAPHIC) — 32KB
- mrm-20250820xex99d1009.jpg (GRAPHIC) — 29KB
- 0001558370-25-011682.txt ( ) — 388KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIROM HEALTHCARE TECHNOLOGIES INC. Date: August 20, 2025 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer